Invention Grant
- Patent Title: Bridged bicyclic nucleosides
-
Application No.: US14771966Application Date: 2014-03-16
-
Publication No.: US10011833B2Publication Date: 2018-07-03
- Inventor: Kurt Vagle
- Applicant: MIRAGEN THERAPEUTICS, INC.
- Applicant Address: US CO Boulder
- Assignee: MIRAGEN THERAPEUTICS, INC.
- Current Assignee: MIRAGEN THERAPEUTICS, INC.
- Current Assignee Address: US CO Boulder
- Agency: Cooley LLP
- International Application: PCT/US2014/030100 WO 20140316
- International Announcement: WO2014/145356 WO 20140918
- Main IPC: C12N15/113
- IPC: C12N15/113 ; C07H19/10 ; C07H21/04 ; C12N15/11
Abstract:
The present invention relates to 2′-C-Bridged Bicyclic Nucleosides and Nucleotides, and oligonucleotides comprising at least one 2′-C-Bridged Bicyclic Nucleotides. The present invention further provides pharmaceutical compositions comprising the nucleosides, nucleotides, and oligonucleotides, as well as their respective methods of use and synthesis.
Public/Granted literature
- US20160010090A1 BRIDGED BICYCLIC NUCLEOSIDES Public/Granted day:2016-01-14
Information query
IPC分类:
